Update on the Roles of Distal Airways in COPD

Overview

Journal Eur Respir Rev

Specialty Pulmonary Medicine

Date 2011 Mar 2

PMID 21357888

Citations 40

Authors

P-R Burgel

A Bourdin

P Chanez

F Chabot

A Chaouat

T Chinet

J de Blic

P Devillier

A Deschildre

A Didier

G Garcia

G Jebrak

F Laurent

H Morel

T Perez

C Pilette

N Roche

I Tillie-Leblond

S Verbanck

D Dusser

Affiliations

Soon will be listed here.

Abstract

This review is the summary of a workshop on the role of distal airways in chronic obstructive pulmonary disease (COPD), which took place in 2009 in Vence, France. The evidence showing inflammation and remodelling in distal airways and the possible involvement of these in the pathobiology, physiology, clinical manifestations and natural history of COPD were examined. The usefulness and limitations of physiological tests and imaging techniques for assessing distal airways abnormalities were evaluated. Ex vivo studies in isolated lungs and invasive measurements of airway resistance in living individuals have revealed that distal airways represent the main site of airflow limitation in COPD. Structural changes in small conducting airways, including increased wall thickness and obstruction by muco-inflammatory exudates, and emphysema (resulting in premature airway closure), were important determinants of airflow limitation. Infiltration of small conducting airways by phagocytes (macrophages and neutrophils), dendritic cells and T and B lymphocytes increased with airflow limitation. Distal airways abnormalities were associated with patient-related outcomes (e.g. dyspnoea and reduced health-related quality of life) and with the natural history of the disease, as reflected by lung function decline and mortality. These data provide a clear rationale for targeting distal airways in COPD.

Citing Articles

Comparing spirometry, impulse oscillometry with computed tomography for assessing small airway dysfunction in subjects with and without chronic obstructive pulmonary disease.

Huang S, Wu F, Deng Z, Peng J, Dai C, Lu L BMC Pulm Med. 2025; 25(1):45.

PMID: 39875840 PMC: 11773755. DOI: 10.1186/s12890-025-03507-1.

In Vitro Analysis of Aerodynamic Properties and Co-Deposition of a Fixed-Dose Combination of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol Trifenatate.

Maneechotesuwan K, Sawatdee S, Srichana T Pharmaceutics. 2024; 16(10).

PMID: 39458663 PMC: 11510472. DOI: 10.3390/pharmaceutics16101334.

Modelling Drug Delivery to the Small Airways: Optimization Using Response Surface Methodology.

Min H, Payne S, Stride E Pharm Res. 2024; 41(6):1139-1148.

PMID: 38755398 PMC: 11525259. DOI: 10.1007/s11095-024-03706-1.

Keratin 15 protects against cigarette smoke-induced epithelial mesenchymal transformation by MMP-9.

Zhu W, Han L, Wu Y, Tong L, He L, Wang Q Respir Res. 2023; 24(1):297.

PMID: 38007424 PMC: 10675954. DOI: 10.1186/s12931-023-02598-w.

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease.

Pelaia C, Procopio G, Rotundo F, Deodato M, Ferrante Bannera A, Tropea F Ther Adv Respir Dis. 2023; 17:17534666231155778.

PMID: 36846944 PMC: 9972048. DOI: 10.1177/17534666231155778.

References

Saetta M, Turato G, Maestrelli P, Mapp C, Fabbri L . Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(6):1304-9. DOI: 10.1164/ajrccm.163.6.2009116. View

Thiberville L, Salaun M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C . Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J. 2009; 33(5):974-85. DOI: 10.1183/09031936.00083708. View

Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp C . Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med. 2000; 161(3 Pt 1):1016-21. DOI: 10.1164/ajrccm.161.3.9907080. View

Kanda S, Fujimoto K, Komatsu Y, Yasuo M, Hanaoka M, Kubo K . Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med. 2010; 49(1):23-30. DOI: 10.2169/internalmedicine.49.2191. View

Dellaca R, Pompilio P, WALKER P, Duffy N, Pedotti A, Calverley P . Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J. 2009; 33(6):1329-37. DOI: 10.1183/09031936.00139608. View

Cazzola M, MacNee W, Martinez F, Rabe K, Franciosi L, Barnes P . Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008; 31(2):416-69. DOI: 10.1183/09031936.00099306. View

Vernooy J, Moller G, van Suylen R, van Spijk M, Cloots R, Hoet P . Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 175(5):464-72. DOI: 10.1164/rccm.200602-169OC. View

Marin J, Carrizo S, Gascon M, Sanchez A, Gallego B, Celli B . Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(6):1395-9. DOI: 10.1164/ajrccm.163.6.2003172. View

Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W . Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med. 2006; 174(8):853-7. DOI: 10.1164/rccm.200603-422OC. View

10.

Bergeron C, Tulic M, Hamid Q . Tools used to measure airway remodelling in research. Eur Respir J. 2007; 29(3):596-604. DOI: 10.1183/09031936.00019906. View

11.

Tsoumakidou M, Koutsopoulos A, Tzanakis N, Dambaki K, Tzortzaki E, Zakynthinos S . Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest. 2009; 136(3):726-733. DOI: 10.1378/chest.08-2824. View

12.

Churg A, Tai H, Coulthard T, Wang R, Wright J . Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med. 2006; 174(12):1327-34. DOI: 10.1164/rccm.200605-585OC. View

13.

Christensson P, ARBORELIUS Jr M . Changes of volume of trapped gas after bronchodilation in subjects with suspected subclinical emphysema. Respiration. 1986; 49(1):16-22. DOI: 10.1159/000194854. View

14.

Demedts I, Bracke K, Van Pottelberge G, Testelmans D, Verleden G, Vermassen F . Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175(10):998-1005. DOI: 10.1164/rccm.200608-1113OC. View

15.

ODonnell D, Revill S, WEBB K . Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164(5):770-7. DOI: 10.1164/ajrccm.164.5.2012122. View

16.

Domagala-Kulawik J, Hoser G, Dabrowska M, Chazan R . Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med. 2006; 101(6):1338-43. DOI: 10.1016/j.rmed.2006.10.004. View

17.

Lee Y, Oh Y, Lee J, Kim E, Lee J, Kim N . Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008; 186(3):157-165. DOI: 10.1007/s00408-008-9071-0. View

18.

Celli B, ZuWallack R, Wang S, Kesten S . Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003; 124(5):1743-8. DOI: 10.1378/chest.124.5.1743. View

19.

Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15):1543-54. DOI: 10.1056/NEJMoa0805800. View

20.

Desai S, Hansell D, Walker A, MacDonald S, Chabat F, Wells A . Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent. Eur Radiol. 2006; 17(4):911-8. DOI: 10.1007/s00330-006-0369-0. View